AveXis Now Known as Novartis Gene Therapies, Focus of Continuing Work
Sep 25, 2020, 12:00 AM
SMA News Today’s multimedia associate, Price Wooldridge, discusses AveXis, now known as Novartis Gene Therapies, focusing on continued work with genetic diseases.
Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/